Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
EDBL · 10-Q filed August 14, 2026

EDBL earnings analysis

What we found in EDBL's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Edible Garden delivered $3.55 million of revenue, beating consensus by 5.0% and growing 12.8% year over year, but diluted EPS of $(18.79) missed expectations by approximately 60.6%. Lower SG&A of $3.1 million, down 21.5%, was not enough to offset the earnings shortfall. The filing adds a material Nasdaq delisting risk tied to a $5 million market-value requirement, with potential suspension after 30 consecutive business days of noncompliance and limited appeal jurisdiction through November 23, 2026.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue beat and grew year over year
Revenue was $3.55 million, $0.169 million or 5.0% above the $3.381 million consensus estimate, and increased 12.8% year over year.
EPS materially missed consensus
Diluted EPS was $(18.79), missing the $(11.70) estimate by $(7.09), or approximately 60.6% below consensus.
Lower SG&A reduced operating pressure
SG&A declined 21.5% to $3.1 million, providing a cost offset despite the quarterly loss.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Nasdaq market-value delisting risk
The company was not in compliance with Nasdaq's proposed $5 million market-value-of-listed-securities requirement as of June 30, 2026. If the requirement takes effect and the deficiency persists for 30 consecutive business days, the securities could be suspended and immediately delisted.
Limited window to cure listing issues
Nasdaq's listing appeal jurisdiction remains in place only through November 23, 2026; a new listing deficiency during that period could give the company just 7 calendar days to present a cure plan to the Panel.
The numbers

What they reported.

What the company itself reported, taken out of the document.

Earnings per share
$-18.79
Guidance

What they said about what is next.

No quantitative forward revenue or EPS guidance was provided in the filing; outlook was deferred to the earnings release/call or otherwise not provided.

How we read the filing overall

The filing reads worse than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-Q · May 15, 2026
Edible Garden reported a 22.9% revenue growth in Q1 2026, reaching approximately $3.34 million, driven primarily by an increase in the cut herb segment. Nonetheless, the company reported a significant net loss of $3.67…
10-K · April 30, 2026
Edible Garden AG reported a challenging fiscal year for 2025, highlighted by a revenue of $4 million, trailing behind prior expectations, and a significantly negative EPS of $(24.81) in Q4. The management noted severe…
10-K · March 31, 2026
Edible Garden describes a strategic pivot from primarily fresh produce to a vertically integrated ready‑to‑drink (RTD) and clean‑nutrition platform ("Farm‑to‑Formula®") by converting its Webster City, IA site into an…
10-Q · November 14, 2025
Edible Garden reported Q3 revenue of $2,817,000 (up $233,000 or ~9.0% vs. Q3 2024) but produced a larger net loss of $(4,045,000) versus $(2,063,000) in the prior-year quarter. Gross profit fell to $273,000 (gross…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing EDBL makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever